Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Interleukin-1 | 29 | 2004 | 1263 | 1.250 |
Why?
|
Babesiosis | 7 | 2022 | 92 | 1.250 |
Why?
|
Clofazimine | 1 | 2022 | 33 | 0.830 |
Why?
|
Wound Infection | 2 | 2023 | 242 | 0.790 |
Why?
|
Adjuvants, Immunologic | 6 | 2018 | 999 | 0.720 |
Why?
|
Lasers | 4 | 2018 | 949 | 0.690 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 687 | 0.610 |
Why?
|
Anti-Infective Agents | 3 | 2023 | 971 | 0.570 |
Why?
|
Vaccines | 4 | 2018 | 823 | 0.560 |
Why?
|
Staphylococcal Infections | 4 | 2023 | 1400 | 0.540 |
Why?
|
Complement Activation | 11 | 1996 | 453 | 0.540 |
Why?
|
Photosensitizing Agents | 5 | 2023 | 602 | 0.480 |
Why?
|
Tumor Necrosis Factor-alpha | 24 | 1997 | 4422 | 0.470 |
Why?
|
Dendritic Cells | 5 | 2018 | 2720 | 0.470 |
Why?
|
HSP70 Heat-Shock Proteins | 4 | 2018 | 403 | 0.440 |
Why?
|
Guillain-Barre Syndrome | 1 | 2013 | 121 | 0.410 |
Why?
|
Glucocorticoids | 1 | 2021 | 2107 | 0.410 |
Why?
|
Skin | 4 | 2018 | 4372 | 0.380 |
Why?
|
Glutathione | 1 | 2013 | 590 | 0.360 |
Why?
|
Herpes Simplex | 1 | 2013 | 470 | 0.360 |
Why?
|
Injections, Intradermal | 3 | 2018 | 117 | 0.350 |
Why?
|
Potassium Iodide | 2 | 2018 | 13 | 0.330 |
Why?
|
Burns | 8 | 2013 | 1815 | 0.320 |
Why?
|
Tetracyclines | 2 | 2018 | 60 | 0.320 |
Why?
|
Erythrocytes | 5 | 2013 | 2455 | 0.310 |
Why?
|
Herpesvirus 1, Human | 1 | 2013 | 743 | 0.310 |
Why?
|
Heterocyclic Compounds | 2 | 2019 | 248 | 0.300 |
Why?
|
Complement C3a | 5 | 2004 | 69 | 0.300 |
Why?
|
Endotoxins | 8 | 1994 | 527 | 0.280 |
Why?
|
Infrared Rays | 3 | 2018 | 249 | 0.280 |
Why?
|
Complement Pathway, Alternative | 6 | 1987 | 126 | 0.280 |
Why?
|
Complement C5a | 10 | 2004 | 107 | 0.250 |
Why?
|
GPI-Linked Proteins | 2 | 2018 | 435 | 0.250 |
Why?
|
Anaphylatoxins | 1 | 2004 | 21 | 0.250 |
Why?
|
Vaccination | 4 | 2018 | 3275 | 0.240 |
Why?
|
Influenza Vaccines | 3 | 2017 | 738 | 0.240 |
Why?
|
Cancer Vaccines | 3 | 2018 | 1023 | 0.230 |
Why?
|
Vitamin K 3 | 1 | 2023 | 15 | 0.230 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3241 | 0.230 |
Why?
|
Anti-Bacterial Agents | 5 | 2023 | 7172 | 0.220 |
Why?
|
Staphylococcus epidermidis | 4 | 1997 | 117 | 0.210 |
Why?
|
Microbial Sensitivity Tests | 3 | 2023 | 1870 | 0.200 |
Why?
|
Monocytes | 3 | 2004 | 2593 | 0.200 |
Why?
|
Lipopolysaccharides | 13 | 1998 | 2217 | 0.200 |
Why?
|
Biofilms | 2 | 2023 | 615 | 0.200 |
Why?
|
Methylene Blue | 2 | 2018 | 155 | 0.190 |
Why?
|
Mast Cells | 2 | 2018 | 1544 | 0.190 |
Why?
|
Leukocytes, Mononuclear | 9 | 1998 | 1836 | 0.180 |
Why?
|
Reactive Oxygen Species | 3 | 2023 | 2077 | 0.180 |
Why?
|
Babesia | 2 | 1998 | 28 | 0.180 |
Why?
|
Mesothelioma | 2 | 2018 | 818 | 0.180 |
Why?
|
Complement C5 | 4 | 1988 | 112 | 0.170 |
Why?
|
Light | 3 | 2020 | 1365 | 0.170 |
Why?
|
Uropathogenic Escherichia coli | 1 | 2018 | 6 | 0.160 |
Why?
|
Photochemotherapy | 3 | 2018 | 808 | 0.160 |
Why?
|
Otitis Media | 1 | 2020 | 277 | 0.150 |
Why?
|
Cystitis, Interstitial | 1 | 1997 | 61 | 0.150 |
Why?
|
Lasers, Semiconductor | 1 | 2017 | 46 | 0.150 |
Why?
|
Recombinant Proteins | 11 | 2014 | 6620 | 0.150 |
Why?
|
Neisseria gonorrhoeae | 1 | 2019 | 238 | 0.140 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 465 | 0.140 |
Why?
|
Lung | 6 | 2013 | 9858 | 0.140 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 412 | 0.140 |
Why?
|
Urticaria | 1 | 1997 | 150 | 0.140 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 892 | 0.140 |
Why?
|
Cellulose | 1 | 1996 | 121 | 0.130 |
Why?
|
Platelet Activation | 2 | 1997 | 674 | 0.130 |
Why?
|
Mastocytosis | 1 | 1997 | 160 | 0.130 |
Why?
|
Acute-Phase Reaction | 1 | 1995 | 92 | 0.130 |
Why?
|
Babesia microti | 2 | 2006 | 31 | 0.130 |
Why?
|
Antibodies, Viral | 3 | 2020 | 3175 | 0.130 |
Why?
|
Gonorrhea | 1 | 2019 | 335 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Sialoglycoproteins | 6 | 2004 | 318 | 0.120 |
Why?
|
Drug Synergism | 7 | 2018 | 1794 | 0.120 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2865 | 0.120 |
Why?
|
Platelet Activating Factor | 1 | 1994 | 149 | 0.120 |
Why?
|
Avidin | 1 | 2014 | 44 | 0.120 |
Why?
|
Membranes, Artificial | 1 | 1996 | 371 | 0.120 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 727 | 0.120 |
Why?
|
Immunomodulation | 1 | 2018 | 541 | 0.120 |
Why?
|
Communicable Diseases, Emerging | 2 | 2014 | 156 | 0.120 |
Why?
|
Lentivirus | 1 | 2016 | 503 | 0.120 |
Why?
|
Cells, Cultured | 12 | 2018 | 19232 | 0.120 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1320 | 0.110 |
Why?
|
Rabbits | 14 | 1994 | 4894 | 0.110 |
Why?
|
Organophosphorus Compounds | 1 | 1994 | 213 | 0.110 |
Why?
|
Receptors, AMPA | 1 | 2015 | 332 | 0.110 |
Why?
|
Shock, Septic | 5 | 1995 | 775 | 0.110 |
Why?
|
Ibuprofen | 3 | 1989 | 236 | 0.110 |
Why?
|
Lassa Fever | 1 | 2014 | 97 | 0.110 |
Why?
|
Erythrocyte Count | 1 | 2013 | 163 | 0.110 |
Why?
|
Humans | 69 | 2023 | 743811 | 0.110 |
Why?
|
Interleukin-2 | 3 | 1995 | 1904 | 0.110 |
Why?
|
Sepsis | 4 | 1994 | 2593 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 3 | 2018 | 3772 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3134 | 0.100 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1172 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1177 | 0.100 |
Why?
|
Complement System Proteins | 4 | 1991 | 796 | 0.100 |
Why?
|
Urinary Tract Infections | 1 | 2018 | 788 | 0.100 |
Why?
|
Laser Therapy | 1 | 2018 | 1071 | 0.100 |
Why?
|
Encephalitis | 1 | 2015 | 424 | 0.100 |
Why?
|
Orthomyxoviridae Infections | 1 | 2013 | 247 | 0.100 |
Why?
|
Urinary Bladder | 1 | 1997 | 1173 | 0.100 |
Why?
|
Radioimmunoassay | 9 | 1993 | 916 | 0.100 |
Why?
|
Pregnadienes | 2 | 1983 | 24 | 0.100 |
Why?
|
Danazol | 2 | 1983 | 42 | 0.090 |
Why?
|
Bacterial Proteins | 2 | 2014 | 3850 | 0.090 |
Why?
|
Wounds and Injuries | 3 | 1995 | 2401 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1670 | 0.090 |
Why?
|
Influenza A virus | 1 | 2013 | 457 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2258 | 0.090 |
Why?
|
Animals | 42 | 2019 | 168660 | 0.090 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 1995 | 612 | 0.090 |
Why?
|
Autoantibodies | 2 | 2015 | 2037 | 0.090 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 4839 | 0.090 |
Why?
|
Blood Coagulation | 1 | 1995 | 1127 | 0.080 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 6 | 2004 | 297 | 0.080 |
Why?
|
Escherichia coli | 6 | 2018 | 4216 | 0.080 |
Why?
|
Blood Platelets | 2 | 1997 | 2509 | 0.080 |
Why?
|
Viral Vaccines | 1 | 2014 | 636 | 0.080 |
Why?
|
Female | 38 | 2020 | 380020 | 0.080 |
Why?
|
Gene Expression | 3 | 2004 | 7793 | 0.080 |
Why?
|
Angioedema | 6 | 1994 | 187 | 0.080 |
Why?
|
Benzylamines | 2 | 2019 | 223 | 0.080 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2007 | 56 | 0.070 |
Why?
|
Biocompatible Materials | 1 | 1996 | 1731 | 0.070 |
Why?
|
Cell Movement | 3 | 2018 | 5216 | 0.070 |
Why?
|
Thiazoles | 1 | 1994 | 1482 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2016 | 3421 | 0.070 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 972 | 0.070 |
Why?
|
Hypotension | 2 | 1993 | 884 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 1988 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3583 | 0.070 |
Why?
|
Oxygen | 2 | 2019 | 4189 | 0.070 |
Why?
|
Dental Implants | 2 | 1992 | 684 | 0.070 |
Why?
|
Hemodynamics | 7 | 1995 | 4197 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3706 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2016 | 1787 | 0.070 |
Why?
|
Drug Approval | 1 | 2012 | 742 | 0.070 |
Why?
|
Receptor, Anaphylatoxin C5a | 2 | 2004 | 90 | 0.070 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1537 | 0.070 |
Why?
|
Pilot Projects | 1 | 2018 | 8316 | 0.060 |
Why?
|
Bacillus | 1 | 2005 | 77 | 0.060 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2005 | 96 | 0.060 |
Why?
|
Mice | 18 | 2019 | 81154 | 0.060 |
Why?
|
Telepathology | 1 | 2005 | 76 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3874 | 0.060 |
Why?
|
Mice, Inbred C57BL | 9 | 2018 | 21824 | 0.060 |
Why?
|
Mycobacterium smegmatis | 1 | 2005 | 122 | 0.060 |
Why?
|
Fever | 4 | 2007 | 1616 | 0.060 |
Why?
|
Pertussis Toxin | 1 | 2004 | 178 | 0.060 |
Why?
|
Cytokines | 3 | 1995 | 7324 | 0.060 |
Why?
|
Neutrophils | 5 | 1994 | 3718 | 0.060 |
Why?
|
Drug Discovery | 1 | 2012 | 1058 | 0.060 |
Why?
|
Pyridines | 1 | 1996 | 2827 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2014 | 3205 | 0.060 |
Why?
|
Antiprotozoal Agents | 2 | 2008 | 86 | 0.060 |
Why?
|
Macrophage-1 Antigen | 1 | 2004 | 290 | 0.060 |
Why?
|
Health Personnel | 1 | 2016 | 3217 | 0.060 |
Why?
|
Osmolar Concentration | 1 | 2004 | 683 | 0.060 |
Why?
|
Vaginal Smears | 1 | 2005 | 511 | 0.050 |
Why?
|
Bacteroides fragilis | 2 | 1985 | 212 | 0.050 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2005 | 387 | 0.050 |
Why?
|
Complement C1 Inactivator Proteins | 3 | 1994 | 93 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11708 | 0.050 |
Why?
|
Blood Pressure | 5 | 1993 | 8551 | 0.050 |
Why?
|
Male | 25 | 2020 | 349776 | 0.050 |
Why?
|
Mice, Inbred BALB C | 4 | 2018 | 6380 | 0.050 |
Why?
|
Cytosol | 1 | 2004 | 901 | 0.050 |
Why?
|
Middle Aged | 13 | 2020 | 213241 | 0.050 |
Why?
|
Complement C4 | 5 | 1983 | 257 | 0.050 |
Why?
|
Adult | 20 | 2020 | 213889 | 0.040 |
Why?
|
Sodium Azide | 1 | 2019 | 24 | 0.040 |
Why?
|
Abetalipoproteinemia | 1 | 2019 | 17 | 0.040 |
Why?
|
Chromatography, Affinity | 1 | 2020 | 549 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2020 | 403 | 0.040 |
Why?
|
Shock | 3 | 1991 | 318 | 0.040 |
Why?
|
Immunity, Innate | 3 | 2020 | 2961 | 0.040 |
Why?
|
Singlet Oxygen | 1 | 2018 | 53 | 0.040 |
Why?
|
DNA Primers | 2 | 2010 | 2891 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4561 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2020 | 1095 | 0.040 |
Why?
|
Biotechnology | 1 | 2020 | 281 | 0.040 |
Why?
|
Arachnid Vectors | 1 | 1998 | 25 | 0.040 |
Why?
|
Dose-Response Relationship, Immunologic | 3 | 1992 | 370 | 0.040 |
Why?
|
Mice, Inbred DBA | 3 | 2006 | 642 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2005 | 2203 | 0.040 |
Why?
|
Ticks | 1 | 1998 | 70 | 0.040 |
Why?
|
Cell Adhesion | 3 | 1998 | 3144 | 0.040 |
Why?
|
T-Lymphocytes | 2 | 1994 | 10179 | 0.040 |
Why?
|
RNA, Messenger | 5 | 1998 | 13028 | 0.040 |
Why?
|
Cell Line | 2 | 2020 | 15993 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 56392 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57744 | 0.040 |
Why?
|
Wound Healing | 1 | 1989 | 2776 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14714 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 100 | 0.040 |
Why?
|
Immunoassay | 1 | 2020 | 751 | 0.040 |
Why?
|
Wounds, Nonpenetrating | 2 | 1995 | 795 | 0.040 |
Why?
|
Cell Degranulation | 1 | 1997 | 287 | 0.040 |
Why?
|
Fibroblasts | 1 | 1987 | 4162 | 0.040 |
Why?
|
Receptors, CCR2 | 1 | 2017 | 212 | 0.040 |
Why?
|
Complement C4a | 1 | 1996 | 19 | 0.030 |
Why?
|
Alkylation | 1 | 1996 | 86 | 0.030 |
Why?
|
Ixodes | 1 | 1996 | 39 | 0.030 |
Why?
|
Arthroscopy | 1 | 2022 | 926 | 0.030 |
Why?
|
Cricetulus | 1 | 2018 | 818 | 0.030 |
Why?
|
Leukocyte Count | 4 | 1994 | 1588 | 0.030 |
Why?
|
Rats | 5 | 2018 | 24250 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23398 | 0.030 |
Why?
|
Adsorption | 1 | 1996 | 201 | 0.030 |
Why?
|
Indomethacin | 1 | 1996 | 332 | 0.030 |
Why?
|
Candidiasis | 1 | 1978 | 366 | 0.030 |
Why?
|
Insect Vectors | 1 | 1996 | 134 | 0.030 |
Why?
|
Binding Sites | 1 | 2004 | 6111 | 0.030 |
Why?
|
Edetic Acid | 1 | 1995 | 274 | 0.030 |
Why?
|
CHO Cells | 1 | 2018 | 1409 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2018 | 730 | 0.030 |
Why?
|
Pyrogens | 1 | 1994 | 17 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 564 | 0.030 |
Why?
|
Ribosomes | 1 | 2018 | 500 | 0.030 |
Why?
|
Blood Bactericidal Activity | 2 | 1987 | 126 | 0.030 |
Why?
|
Up-Regulation | 1 | 2004 | 4221 | 0.030 |
Why?
|
Complement C3 | 3 | 1991 | 461 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 2018 | 532 | 0.030 |
Why?
|
Cats | 1 | 1996 | 986 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2019 | 3690 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 1995 | 420 | 0.030 |
Why?
|
HLA-DR3 Antigen | 1 | 2014 | 34 | 0.030 |
Why?
|
Thrombin | 1 | 1997 | 598 | 0.030 |
Why?
|
Tyrosine | 1 | 2018 | 1462 | 0.030 |
Why?
|
Cricetinae | 1 | 2018 | 2475 | 0.030 |
Why?
|
Vagina | 1 | 2019 | 825 | 0.030 |
Why?
|
C-Reactive Protein | 4 | 1991 | 3778 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1255 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 589 | 0.030 |
Why?
|
Syphilis | 1 | 1976 | 227 | 0.030 |
Why?
|
Platelet Count | 2 | 1994 | 780 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 10940 | 0.030 |
Why?
|
Penicillins | 1 | 1976 | 380 | 0.030 |
Why?
|
Bacteroides Infections | 2 | 1985 | 82 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 715 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6170 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9731 | 0.030 |
Why?
|
Interleukin-8 | 2 | 1993 | 690 | 0.030 |
Why?
|
Lassa virus | 1 | 2014 | 97 | 0.030 |
Why?
|
Hepatitis | 1 | 1995 | 227 | 0.030 |
Why?
|
Computational Biology | 1 | 2005 | 3515 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2005 | 2018 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18027 | 0.030 |
Why?
|
Russia | 1 | 2014 | 408 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4749 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1663 | 0.030 |
Why?
|
Granuloma | 1 | 1995 | 319 | 0.030 |
Why?
|
Surface Properties | 1 | 1996 | 1168 | 0.030 |
Why?
|
Serum Albumin | 1 | 1996 | 675 | 0.030 |
Why?
|
Multiple Organ Failure | 1 | 1995 | 389 | 0.030 |
Why?
|
Adolescent | 6 | 2018 | 85729 | 0.030 |
Why?
|
Aged | 10 | 2020 | 163178 | 0.030 |
Why?
|
Macrophage Activation | 1 | 1995 | 559 | 0.030 |
Why?
|
Ovalbumin | 1 | 2014 | 719 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 16674 | 0.030 |
Why?
|
Pulmonary Surfactants | 2 | 1989 | 162 | 0.030 |
Why?
|
Base Sequence | 2 | 2010 | 12798 | 0.030 |
Why?
|
Leishmaniasis, Visceral | 1 | 1992 | 94 | 0.020 |
Why?
|
Hemorrhage | 2 | 1995 | 3458 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 1994 | 414 | 0.020 |
Why?
|
Choline | 2 | 1989 | 492 | 0.020 |
Why?
|
Dogs | 1 | 1996 | 3911 | 0.020 |
Why?
|
Cell Separation | 1 | 1997 | 1750 | 0.020 |
Why?
|
Calcium | 1 | 2004 | 5755 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6457 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1030 | 0.020 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 1989 | 43 | 0.020 |
Why?
|
Occupational Health | 1 | 2016 | 808 | 0.020 |
Why?
|
Cattle | 1 | 1996 | 3917 | 0.020 |
Why?
|
Protein Engineering | 1 | 2014 | 539 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8385 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3128 | 0.020 |
Why?
|
Mice, SCID | 2 | 2006 | 2718 | 0.020 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2014 | 459 | 0.020 |
Why?
|
Massachusetts | 2 | 2020 | 8660 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13112 | 0.020 |
Why?
|
Osseointegration | 1 | 1991 | 262 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 1989 | 162 | 0.020 |
Why?
|
Meningococcal Infections | 1 | 1989 | 77 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 77410 | 0.020 |
Why?
|
Polymyxin B | 1 | 1988 | 46 | 0.020 |
Why?
|
Serum Amyloid P-Component | 1 | 1988 | 47 | 0.020 |
Why?
|
Pancreatic Elastase | 1 | 1988 | 136 | 0.020 |
Why?
|
Plasmapheresis | 1 | 1989 | 211 | 0.020 |
Why?
|
Pseudomonas | 1 | 1988 | 117 | 0.020 |
Why?
|
Methotrexate | 1 | 1995 | 1726 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8637 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1988 | 329 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1998 | 3208 | 0.020 |
Why?
|
Lyme Disease | 1 | 1994 | 621 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6363 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1989 | 768 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2014 | 1821 | 0.020 |
Why?
|
Blood Transfusion | 2 | 1993 | 1301 | 0.020 |
Why?
|
Spherocytosis, Hereditary | 1 | 2007 | 80 | 0.020 |
Why?
|
Muramidase | 1 | 1987 | 174 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1996 | 6356 | 0.020 |
Why?
|
Quinolinium Compounds | 1 | 2006 | 15 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12243 | 0.020 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1989 | 371 | 0.020 |
Why?
|
Zoonoses | 1 | 2008 | 183 | 0.020 |
Why?
|
Heart | 1 | 2020 | 4460 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3953 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 2 | 1987 | 675 | 0.020 |
Why?
|
Hematologic Tests | 1 | 2007 | 240 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1995 | 1888 | 0.020 |
Why?
|
Superoxides | 1 | 1987 | 387 | 0.020 |
Why?
|
Vascular Resistance | 1 | 1989 | 936 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 6311 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4204 | 0.020 |
Why?
|
Chromatography, Gas | 1 | 2005 | 156 | 0.020 |
Why?
|
Recurrence | 2 | 2008 | 8337 | 0.020 |
Why?
|
Splenectomy | 1 | 2007 | 394 | 0.020 |
Why?
|
Benzoxazoles | 1 | 2006 | 79 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 1994 | 1199 | 0.020 |
Why?
|
Biopsy | 1 | 1997 | 6750 | 0.020 |
Why?
|
Immunity, Cellular | 2 | 1984 | 1608 | 0.020 |
Why?
|
Spleen | 2 | 2004 | 2359 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1995 | 18107 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8655 | 0.020 |
Why?
|
Complement C3b | 1 | 1984 | 106 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2006 | 296 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1962 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 2006 | 323 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6539 | 0.020 |
Why?
|
Biological Assay | 1 | 1987 | 650 | 0.020 |
Why?
|
Kinetics | 4 | 1994 | 6476 | 0.010 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1983 | 43 | 0.010 |
Why?
|
Lymphocytes | 1 | 1991 | 2615 | 0.010 |
Why?
|
Zymosan | 1 | 1983 | 124 | 0.010 |
Why?
|
Parasitemia | 1 | 2004 | 173 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9944 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6895 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1990 | 2123 | 0.010 |
Why?
|
Complement Pathway, Classical | 1 | 1982 | 97 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2014 | 1832 | 0.010 |
Why?
|
Automation | 1 | 2005 | 584 | 0.010 |
Why?
|
Hemophilia B | 1 | 1983 | 81 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2008 | 847 | 0.010 |
Why?
|
Elapid Venoms | 2 | 1980 | 40 | 0.010 |
Why?
|
Critical Care | 1 | 1995 | 2647 | 0.010 |
Why?
|
Magnesium Chloride | 1 | 1981 | 32 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1993 | 3038 | 0.010 |
Why?
|
Diagnosis, Differential | 3 | 2007 | 12954 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1981 | 173 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2005 | 590 | 0.010 |
Why?
|
Phagocytosis | 1 | 1987 | 1539 | 0.010 |
Why?
|
Lymphokines | 1 | 1984 | 948 | 0.010 |
Why?
|
Bacteroides | 1 | 1981 | 161 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4386 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10251 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1993 | 4459 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10380 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1995 | 3142 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15281 | 0.010 |
Why?
|
Body Temperature | 2 | 1994 | 774 | 0.010 |
Why?
|
Hemophilia A | 1 | 1983 | 351 | 0.010 |
Why?
|
Species Specificity | 1 | 2004 | 2480 | 0.010 |
Why?
|
Dyspnea | 1 | 2007 | 1303 | 0.010 |
Why?
|
Papillomaviridae | 1 | 2005 | 1119 | 0.010 |
Why?
|
Complement Activating Enzymes | 1 | 1978 | 28 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1995 | 4260 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1987 | 1453 | 0.010 |
Why?
|
Sialic Acids | 1 | 1979 | 128 | 0.010 |
Why?
|
Time Factors | 5 | 1992 | 40038 | 0.010 |
Why?
|
Tritium | 2 | 1989 | 745 | 0.010 |
Why?
|
Neuraminidase | 1 | 1979 | 210 | 0.010 |
Why?
|
Syndrome | 2 | 1993 | 3249 | 0.010 |
Why?
|
Magnesium | 1 | 1981 | 813 | 0.010 |
Why?
|
Mitogens | 1 | 1998 | 232 | 0.010 |
Why?
|
Incidence | 2 | 1994 | 20948 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1524 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6487 | 0.010 |
Why?
|
Energy Metabolism | 1 | 1988 | 2899 | 0.010 |
Why?
|
Esterases | 1 | 1976 | 95 | 0.010 |
Why?
|
Melanoma | 1 | 1995 | 5508 | 0.010 |
Why?
|
Hemolysis | 1 | 1979 | 420 | 0.010 |
Why?
|
Treponema pallidum | 1 | 1976 | 40 | 0.010 |
Why?
|
Abscess | 1 | 1980 | 607 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1978 | 1386 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1990 | 7719 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 7010 | 0.010 |
Why?
|
Proteins | 1 | 1991 | 6098 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 72252 | 0.010 |
Why?
|
Antigens, CD | 1 | 2006 | 4026 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5973 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2005 | 5078 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1976 | 647 | 0.010 |
Why?
|
Menstruation | 1 | 1976 | 302 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23327 | 0.010 |
Why?
|
Candida albicans | 1 | 1978 | 394 | 0.010 |
Why?
|
Erythema | 1 | 1976 | 257 | 0.010 |
Why?
|
Digestive System | 1 | 1995 | 253 | 0.010 |
Why?
|
Adhesiveness | 1 | 1994 | 53 | 0.010 |
Why?
|
Quinine | 1 | 1994 | 54 | 0.010 |
Why?
|
Erythrocyte Deformability | 1 | 1994 | 56 | 0.010 |
Why?
|
Neoplasms | 2 | 2014 | 21675 | 0.010 |
Why?
|
Clindamycin | 1 | 1994 | 139 | 0.010 |
Why?
|
Permeability | 1 | 1995 | 738 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2005 | 1587 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39001 | 0.010 |
Why?
|
Inflammation | 1 | 1993 | 10629 | 0.010 |
Why?
|
Receptors, Complement | 1 | 1994 | 264 | 0.010 |
Why?
|
Internet | 1 | 2005 | 3058 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 63042 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1994 | 376 | 0.010 |
Why?
|
Umbilical Veins | 1 | 1993 | 433 | 0.010 |
Why?
|
Acute Disease | 2 | 1994 | 7150 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1992 | 326 | 0.010 |
Why?
|
Body Surface Area | 1 | 1992 | 199 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1993 | 425 | 0.010 |
Why?
|
Burn Units | 1 | 1992 | 136 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1993 | 262 | 0.010 |
Why?
|
Immune Sera | 1 | 1992 | 641 | 0.010 |
Why?
|
Complement Membrane Attack Complex | 1 | 1991 | 112 | 0.010 |
Why?
|
Mucus | 1 | 1993 | 321 | 0.010 |
Why?
|
Skin Diseases | 1 | 1980 | 1066 | 0.010 |
Why?
|
Pneumonia | 1 | 1983 | 2133 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1983 | 2134 | 0.010 |
Why?
|
Teichoic Acids | 1 | 1991 | 66 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2274 | 0.010 |
Why?
|
Liver | 2 | 1994 | 7479 | 0.010 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 222 | 0.010 |
Why?
|
Child | 3 | 1995 | 77637 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 1992 | 250 | 0.010 |
Why?
|
Surface Tension | 1 | 1989 | 47 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 21733 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1995 | 1181 | 0.010 |
Why?
|
Autoantigens | 1 | 1994 | 892 | 0.010 |
Why?
|
Epinephrine | 1 | 1993 | 792 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1990 | 821 | 0.010 |
Why?
|
Rectum | 1 | 1994 | 904 | 0.010 |
Why?
|
Sex Factors | 1 | 1983 | 10394 | 0.010 |
Why?
|
Organ Specificity | 1 | 1994 | 2008 | 0.010 |
Why?
|
Neisseria meningitidis | 1 | 1989 | 109 | 0.010 |
Why?
|
Cell Membrane | 1 | 1979 | 3749 | 0.010 |
Why?
|
Pulse | 1 | 1988 | 228 | 0.010 |
Why?
|
Glycoproteins | 1 | 1976 | 2266 | 0.010 |
Why?
|
Headache | 1 | 1976 | 1224 | 0.010 |
Why?
|
Brain | 1 | 2015 | 26345 | 0.000 |
Why?
|
Hospitals, General | 1 | 1992 | 749 | 0.000 |
Why?
|
alpha 1-Antitrypsin | 1 | 1988 | 163 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2570 | 0.000 |
Why?
|
Carbon Radioisotopes | 1 | 1988 | 577 | 0.000 |
Why?
|
Administration, Oral | 1 | 1995 | 3912 | 0.000 |
Why?
|
Fluid Therapy | 1 | 1991 | 593 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2005 | 19894 | 0.000 |
Why?
|
Necrosis | 1 | 1991 | 1642 | 0.000 |
Why?
|
Immunotherapy | 2 | 1993 | 4437 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1989 | 688 | 0.000 |
Why?
|
Glucagon | 1 | 1988 | 533 | 0.000 |
Why?
|
Bacteremia | 1 | 1993 | 963 | 0.000 |
Why?
|
Liposomes | 1 | 1989 | 759 | 0.000 |
Why?
|
Iodine Radioisotopes | 1 | 1989 | 1035 | 0.000 |
Why?
|
United States | 1 | 2014 | 69859 | 0.000 |
Why?
|
Body Weight | 1 | 1976 | 4670 | 0.000 |
Why?
|
Cell Communication | 1 | 1993 | 1621 | 0.000 |
Why?
|
Reference Values | 1 | 1992 | 4974 | 0.000 |
Why?
|
Carbon Dioxide | 1 | 1988 | 1150 | 0.000 |
Why?
|
Amyloid | 1 | 1988 | 795 | 0.000 |
Why?
|
Respiration, Artificial | 1 | 1994 | 2568 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1988 | 2183 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8300 | 0.000 |
Why?
|
Liver Diseases | 1 | 1991 | 1253 | 0.000 |
Why?
|
Kidney | 1 | 1978 | 7185 | 0.000 |
Why?
|
Oxygen Consumption | 1 | 1988 | 1869 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1994 | 13809 | 0.000 |
Why?
|
Respiration | 1 | 1988 | 1653 | 0.000 |
Why?
|
Peptides | 1 | 1994 | 4406 | 0.000 |
Why?
|
Swine | 1 | 1991 | 5909 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1989 | 1826 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1976 | 7908 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1991 | 5524 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1980 | 419 | 0.000 |
Why?
|
Cecum | 1 | 1980 | 237 | 0.000 |
Why?
|
Prospective Studies | 2 | 1995 | 53250 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1985 | 2375 | 0.000 |
Why?
|
Survival Rate | 1 | 1992 | 12786 | 0.000 |
Why?
|
Methyltestosterone | 1 | 1976 | 19 | 0.000 |
Why?
|
Glucose | 1 | 1988 | 4398 | 0.000 |
Why?
|
Complement Inactivator Proteins | 1 | 1976 | 79 | 0.000 |
Why?
|
DNA | 1 | 1989 | 7295 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 1992 | 15526 | 0.000 |
Why?
|
Tranexamic Acid | 1 | 1976 | 146 | 0.000 |
Why?
|
Insulin | 1 | 1988 | 6584 | 0.000 |
Why?
|
Mice, Nude | 1 | 1980 | 3680 | 0.000 |
Why?
|
Prognosis | 1 | 1992 | 29052 | 0.000 |
Why?
|
Progesterone | 1 | 1976 | 773 | 0.000 |
Why?
|
Child, Preschool | 1 | 1992 | 40964 | 0.000 |
Why?
|
Pedigree | 1 | 1976 | 4643 | 0.000 |
Why?
|
Intubation, Intratracheal | 1 | 1976 | 1365 | 0.000 |
Why?
|
Pregnancy | 1 | 1976 | 29140 | 0.000 |
Why?
|